Suppression of chloride voltage-gated channel 3 expression increases sensitivity of human glioma U251 cells to

Yihe Zhang1,2, Lei Zhou3, Juanjuan Zhang1

  • 1Department of Pathophysiology, Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China.

Oncology Letters
|July 3, 2018
PubMed

Insights

Suppression of chloride voltage-gated channel 3 (CLCN3) enhances cisplatin

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cisplatin resistance is a significant challenge in glioma treatment.
  • Chloride voltage-gated channel 3 (CLCN3) has been implicated in drug resistance, but its precise role in cisplatin resistance remains unclear.
  • Understanding the mechanisms of cisplatin resistance is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To investigate the role of CLCN3 in cisplatin resistance in human glioma U251 cells.
  • To explore the effects of combined cisplatin treatment and CLCN3 suppression on glioma cell viability and apoptosis.
  • To elucidate the underlying mechanisms, particularly lysosomal function, by which CLCN3 influences cisplatin sensitivity.

Main Methods:

  • Human glioma U251 cells were treated with cisplatin alone or in combination with CLCN3 antisense.
  • Cell viability was assessed to determine cytotoxic effects.
  • Apoptosis-related gene expression (TP53, BCL2/BAX ratio) and caspase 3 activation were analyzed.
  • Lysosome stabilization was evaluated in cisplatin-treated cells with and without CLCN3 suppression.

Main Results:

  • CLCN3 suppression significantly decreased the viability of cisplatin-treated U251 cells.
  • Combined treatment enhanced apoptosis, indicated by increased TP53 expression, caspase 3 activation, and a decreased BCL2/BAX ratio.
  • CLCN3 suppression led to decreased lysosome stabilization in cisplatin-treated U251 cells, suggesting lysosomal dysfunction.

Conclusions:

  • CLCN3 suppression sensitizes human glioma cells to cisplatin.
  • The combination of cisplatin and CLCN3 antisense exhibits additive cytotoxic effects.
  • Lysosomal dysfunction induced by CLCN3 suppression is a key mechanism mediating enhanced cisplatin sensitivity in glioma cells.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
10.9K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.3K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.8K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
14.4K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
5.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.1K